Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure
about
Prospects for lentiviral vector mediated prostaglandin F synthase gene delivery in monkey eyes in vivoExciting directions in glaucomaApplication of canaloplasty in glaucoma gene therapy: where are we?Glaucoma: genes, phenotypes, and new directions for therapy.Capsid Mutated Adeno-Associated Virus Delivered to the Anterior Chamber Results in Efficient Transduction of Trabecular Meshwork in Mouse and RatRegionally Discrete Aqueous Humor Outflow Quantification Using Fluorescein Canalograms.Elevation of intraocular pressure in rodents using viral vectors targeting the trabecular meshwork.Gene therapy strategies in glaucoma and application for steroid-induced hypertensionEnhancing titres of therapeutic viral vectors using the transgene repression in vector production (TRiP) system.Ocular gene delivery using lentiviral vectors.The Pathway From Genes to Gene Therapy in Glaucoma: A Review of Possibilities for Using Genes as Glaucoma Drugs.Gene transfer to the outflow tract.Microarray-based analysis of gene expression profiles in peripheral blood of patients with acute primary angle closure.Glaucoma, Stem Cells, and Gene Therapy: Where Are We Now?Proteasome Inhibition Increases the Efficiency of Lentiviral Vector-Mediated Transduction of Trabecular Meshwork.Cyclooxygenase 2: protein-protein interactions and posttranslational modifications.
P2860
Q27024271-FF40BA31-F876-48BC-A1FB-AD417DEDFFD5Q28542397-89F61FCD-8FB8-435E-8890-034446B1347EQ30576377-2030750E-5A9A-4E11-8223-1263D20BAA99Q34090204-AFE6E9F3-EF3D-4B31-8C2F-44C6CC512054Q35656153-B08D59CA-D158-4741-8C6D-2CC4B06CE5E6Q35964603-A1EBD337-3A41-4281-B8F5-E209DC725395Q36236887-BC48B6EC-B8FD-4908-914B-11D6E5F11DADQ37060277-04D1535A-5BFC-4156-905D-F6F0778A086DQ37736299-B1CCD1AB-33FA-4138-9FFB-D4F39080A271Q37952564-A706A942-1E91-4C4E-BB18-E3C689A30A1AQ38761425-BB6746F0-1E5B-4169-A60D-6170BDF15BC4Q38821882-F36ED4C0-B666-458F-817D-A94C3A33F8B7Q38890553-C1128BD2-3D71-417C-90DC-A545CDBCE4FAQ45871232-CE5ED993-A7CF-4BC2-9766-6AEC1443495BQ47552653-3E83ED25-1174-4763-9D82-D21F86B20881Q47758719-91F5B7A9-C02E-451C-A273-0BDDF6263768
P2860
Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure
@ast
Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure
@en
type
label
Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure
@ast
Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure
@en
prefLabel
Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure
@ast
Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure
@en
P2093
P2860
P356
P1433
P1476
Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure
@en
P2093
Eric M Poeschla
Jay W McLaren
Román A Barraza
P2860
P304
P356
10.1038/MT.2009.278
P577
2009-12-01T00:00:00Z